Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
eNq1mN9v2jAQx9/5K6K8kxDoL6ZAtbF2Q2o1Ros27aUyyVHMXDs920D3188hdKOTo64GP8Z2vnf23X18cnq+fmDBElBSwXthErXCAHgmcsrve+Hk9rJ5Fp73G+mCLMnOstOoFSXtMMgYkbIXlrPRFAiX0ffrq49g/gcM+40gFdMFZOrFOq0oiz4TOb8mRbkmSJeC5sEDqLnIe2Gh1WY0SKVC40V/JfCnLEgGabwd2Z1d3B3tjqdxKfYfqloCXhF+bxUF7qSZaUTgakAU3At8qvG346RN5Rik0JjBiKj5CMWS5pBbTcwIk+BkZLbKbwCXDFRpxCoeL7IH6SROFmQ9hseh3en3Znag1qrZaianR91296jd6ZwkboeFO0dlj4LZRJzdJaftdrfViYHHjHClpWNoRgIVYZ6CQuXgZV55soPw+GrwcyoLRp6ihSxcj4ogMdOApvr9baTcwS0aHjFzZv/oc81Y/EavJ1taePK4hNFAaK5qoHE5dj2IgeAK1vURdeOcWm9zkYI8nOwvwe2MH+kpo5kr0QxzNEg1GQ/rgXZAFnwgEiboDwbfKM/FSh4eMrtB9eR9seGkVbTAPLlrd89OkuNj5xr6YTKo5n650CgKiA1+qNyHKkM+E/vyxCSlXeo5JQ+VjZsmR2SEQU2b03Qki0nD567MW6L7K6Jqwir66eLWNTu+asCnm82nVZrmvT9xdcOuD5abXKx1/O2ZXRW4lwZYox0cc6UK+S6OV6tVNCeyKU25QDTDQ3N95yb11317ua6r9qVioyfXp9Wl97YAuRbaaxf6vk3q9v9tM2y1oVDDHrGomOyNnMOLw8P4b4fqze3RC3j4M7PpJomigvtqc/TUqrgf/k1c+SUaQHyZzWjNa0htXqZx9RLTb6Rx+QrTb/wGgAnjOA==
afhprSq6QpYEE7qA
Listen
